Better Therapeutics is advancing human health through the power of behavior change. Pioneering a prescription digital therapeutics platform for treating cardiometabolic diseases, Better Therapeutics is innovating at the intersection of technology, psychology and medicine. Using the gold standard of evidence based therapy, Cognitive Behavioral Therapy (CBT), the first product to receive FDA authorization to treat adults with type 2 diabetes is AspyreRx. Using proven techniques that target the underlying psychological, behavioral and cognitive factors that sustain or worsen T2D, AspyreRx is prescribed by a healthcare provider in 90-day increments, with proprietary CBT delivered digitally in a weekly step-by-step process. Through interactive therapy lessons, skill-building modules, weekly goal setting and tracking, patients connect changes in behavior to improvements in blood sugar and other biometrics. Each step in the experience builds on the prior to enable and reinforce cognitive restructuring, building the emotional resilience and acceptance needed to make enduring changes. AspyreRx is backed by robust data demonstrating clinically meaningful and sustained reduction in HbA1c when used up to 180 days.
STEP 1: Download the ACLM Lifestyle Medicine app to your device.
Available for iOS or Android. Requires iOS 12.0 or later. Compatible with iPhone, iPad, and iPod touch. Requires Android 6.0 and up.
STEP 2: Share your profile with attendees and exhibitors (required to play)
STEP 3: Visit participating exhibit booths in-person and/or online
STEP 4: Answer questions to earn points
STEP 5: Watch for the winner!
At the conclusion of the conference, one winner will be drawn from the group of attendees who earn the most points. Winner will be notified via email on or before Friday, November 10.